Egr-1 is upregulated in primary human prostate carcinomas [41,42,43] and in numerous downstream Egr-1 genes (e.g., transforming growth factor β1, insulin-like growth factor II, and platelet-derived growth factor A-chain), that have been connected to prostate cancer [44]. Here, IGF2 is linked to prostate carcinoma.